Home / Stocks / PHIO

PHIO insider trading

Phio Pharmaceuticals Corp. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
12
Bought · 24 mo
$87k
Buys · last 90 days
3 · $38k
Most recent buy
2026-08-20

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-20Plott Ronald Todd
Director
Bought15,000$1.14$17k
2026-08-19Bitterman Robert J
Chairman, Pres. & CEO
Bought10,000$1.06$11k
2026-06-29Bitterman Robert J
Chairman, Pres. & CEO
Bought10,000$0.99$10k
2026-01-02Bitterman Robert J
Chairman, Pres. & CEO
Bought5,000$1.03$5k
2025-12-29Bitterman Robert J
Chairman, Pres. & CEO
Bought5,000$1.02$5k
2025-11-24Bitterman Robert J
Chairman, Pres. & CEO
Bought5,000$1.14$6k
2025-11-19Bitterman Robert J
Chairman, Pres. & CEO
Bought5,000$1.27$6k
2025-06-11Bitterman Robert J
Chairman, Pres & CEO
Bought2,000$2.42$5k
2025-06-11Ferrara Robert L
Director
Bought2,500$2.42$6k
2025-06-10Bitterman Robert J
Chairman, Pres & CEO
Bought1,500$2.75$4k
2025-05-23Bitterman Robert J
Chairman, Pres & CEO
Bought4,200$1.77$7k
2025-05-21Ferrara Robert L
Director
Bought2,500$1.82$5k

Most active insider buyers

InsiderRoleBuysTotal bought
Bitterman Robert JChairman, Pres. & CEO9$59k
Plott Ronald ToddDirector1$17k
Ferrara Robert LDirector2$11k

See PHIO on the chart

Every insider buy and sell for PHIO plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.